Edition:
United States

MabVax Therapeutics Holdings Inc (MBVX.OQ)

MBVX.OQ on NASDAQ Stock Exchange Capital Market

0.80USD
15 Dec 2017
Change (% chg)

$-0.01 (-1.23%)
Prev Close
$0.81
Open
$0.85
Day's High
$0.85
Day's Low
$0.77
Volume
26,411
Avg. Vol
69,816
52-wk High
$3.83
52-wk Low
$0.43

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 0.00 -0.540
Jun '17 0.00 -1.465
Mar '17 0.00 -0.850
FY 2016 Dec '16 0.00 -0.810
Sep '16 0.00 -0.864
Jun '16 0.00 -0.917
Mar '16 0.15 -1.116
FY 2015 Dec '15 0.76 -1.038
Sep '15 0.13 -1.515
Jun '15 0.14 -2.181
Mar '15 0.24 -46.253
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 198.20 35.91
P/E High - Last 5 Yrs. -- 280.37 45.35
P/E Low - Last 5 Yrs. -- 93.75 24.23
Beta 1.53 0.82 0.91
Price to Sales (TTM) -- 122.78 5.95
Price to Book (MRQ) 6.08 23.45 5.68
Price to Tangible Book (MRQ) -- 27.39 7.29
Price to Cash Flow (TTM) -- 108.78 24.49
% Owned Institutions 0.79 5.61 1.41

Dividends

  Company industry sector
Dividend Yield -- 0.28 1.49
Dividend Yield - 5 Year Avg -- 0.26 2.05
Dividend 5 Year Growth Rate -- 1.99 5.25
Payout Ratio(TTM) -- 96.58 46.14

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- -5.04 6.79
Sales (TTM) vs TTM 1 Yr. Ago -100.00 29.98 5.62
Sales - 5 Yr. Growth Rate -- 33.48 10.24
EPS (MRQ) vs Qtr. 1 Yr. Ago 37.58 -150.15 7.85
EPS (TTM) vs TTM 1 Yr. Ago 6.89 -- --
EPS - 5 Yr. Growth Rate -- 44.93 10.94
Capital Spending - 5 Yr. Growth Rate -- 41.51 15.17

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.79 2.55
Current Ratio (MRQ) 0.54 5.62 3.56
LT Debt to Equity (MRQ) 79.67 16.22 13.38
Total Debt to Equity (MRQ) 147.54 18.71 19.38
Interest Coverage (TTM) -21.67 -139.32 44.30

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 44.18 54.91
Gross Margin - 5 Yr. Avg. -- 55.78 52.46
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -2,627.94 -215.66 15.63
Operating Margin (TTM) -- -642.63 6.56
Operating Margin - 5 Yr. Avg. -2,634.20 -232.87 11.00
Pre-Tax Margin (TTM) -- -611.04 7.41
Pre-Tax Margin - 5 Yr. Avg. -2,657.88 -233.04 11.41
Net Profit Margin (TTM) -- -608.78 3.64
Net Profit Margin - 5 Yr. Avg. -2,657.88 -236.43 7.70
Effective Tax Rate (TTM) -- 15.53 24.28
Effective Tax Rate - 5 Yr. Avg. -- 19.13 24.07

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 22,314,532 851,801,741
Net Income/Employee (TTM) -- -1,997,855 99,542,701
Receivable Turnover (TTM) -- 26.15 6.13
Inventory Turnover (TTM) -- 2.62 3.56
Asset Turnover (TTM) 0.00 0.42 0.96

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -149.15 -9.39 11.31
Return on Assets - 5 Yr. Avg. -141.07 0.28 12.28
Return on Investment (TTM) -251.91 -11.76 14.43
Return on Investment - 5 Yr. Avg. -232.15 3.42 16.07
Return on Equity (TTM) -557.65 -36.72 16.01
Return on Equity - 5 Yr. Avg. -2,634.24 5.75 17.27
  1 Year 3 Year 5 Year
Sales % -88.32 -26.07 --
EPS (TTM) % 72.96 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for MabVax Therapeutics Holdings Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 0.76%
# of Holders: 14
Total Shares Held: 156,024
3 Mo. Net Change: 61,831
# New Positions: 4
# Closed Positions: 1
# Increased Positions: 5
# Reduced Positions: 2
# Net Buyers: 3
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.